Overview and structural analysis of levofloxacin

Levofloxacin is a broad-spectrum antibacterial drug and a third-generation quinolone antibiotic. It is mainly used to treat infections of the respiratory tract, genitourinary system, skin and soft tissues caused by sensitive bacteria. This article will start fromPharmacological effects, indications, usage and dosage, adverse reactions and manufacturerIt is developed in five aspects, focusing on its antibacterial mechanism and clinical value, and secondarily explaining precautions and common preparations on the market.

Pharmacological effects and antibacterial mechanisms

Levofloxacin blocks DNA replication by inhibiting bacterial DNA gyrase and topoisomerase IV, and has significant effects on Gram-positive bacteria, negative bacteria and some anaerobic bacteria. Its levorotatory isomer (levofloxacin) is more active than ofloxacin, and its bioavailability is as high as 99%. Clinical studies have shown that the drug has a low MIC (minimum inhibitory concentration) against common pathogens such as Streptococcus pneumoniae and Escherichia coli (

Bacteria	MIC90 (μg/mL)
Streptococcus pneumoniae	1.0
Escherichia coli	0.5

), data comes from "Chinese Journal of Infection and Chemotherapy".

Indications and clinical applications

Levofloxacin is suitable forlower respiratory tract infection(such as community-acquired pneumonia),complicated urinary tract infectionandacute pyelonephritis. According to the "Heat Disease" guideline recommendations, the adult dose is usually 250-750 mg/day, and the treatment course is 7-14 days. It should be noted that this drug is not suitable for adolescents under 18 years old and pregnant women because it may affect cartilage development. Drug susceptibility test results must be strictly followed in clinical use to avoid abuse leading to drug resistance.

Adverse reactions and precautions

Common adverse reactions include gastrointestinal reactions (nausea, diarrhea), central nervous system symptoms (headache, insomnia) and photosensitivity reactions. The rare but serious risk of QT prolongation requires caution, especially in patients with heart disease. The U.S. FDA has issued a warning that quinolones may worsen myasthenia symptoms. Avoid taking aluminum/magnesium-containing antacids at the same time during medication, and keep at least 2 hours apart to ensure absorption.

Manufacturers and Market Preparations

Major domestic manufacturers includeZhejiang Pharmaceutical Co., Ltd.(Product name: Zuo Ke),Yangzijiang Pharmaceutical(Product name: Yangdefei) andDaiichi Sankyo Pharmaceutical(Original drug: Levaquin). The dosage forms include tablets (0.25g/tablet), injection (0.5g/100mL) and eye drops. According to data from Minai.com, the domestic market sales of levofloxacin will exceed 1.5 billion yuan in 2022, ranking among the TOP5 systemic antibacterial drugs.

Citing sources

1. Pharmacological data: "Chinese Journal of Infection and Chemotherapy" 2019 Issue 3
2. Clinical Guideline: "Fever: Sanford Guidelines for Antimicrobial Treatment" (52nd edition)
3. Manufacturer: Official website of the National Medical Products Administration (NMPA)
4. Market data: Minenet's "Blue Book of China's Pharmaceutical Market" 2023